Ropenia Injection 300 mcg/0.5 ml contains Filgrastim, a recombinant human granulocyte colony-stimulating factor (G-CSF) that stimulates the production of neutrophils, a type of white blood cell essential for fighting infections. It is commonly prescribed for patients experiencing neutropenia due to chemotherapy, bone marrow transplantation, or other conditions that compromise immune function. By increasing neutrophil counts, Ropenia helps reduce the risk of infection and supports immune recovery.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Filgrastim 300 mcg per 0.5 ml
• Dosage Form: Injectable solution

Indications

Ropenia Injection is indicated for:

• Prevention of chemotherapy-induced neutropenia and associated infections
• Treatment of severe chronic neutropenia
• Mobilization of hematopoietic stem cells for bone marrow transplantation
• Accelerating neutrophil recovery following bone marrow transplantation

Mechanism of Action

Filgrastim is a recombinant form of granulocyte colony-stimulating factor (G-CSF). It binds to specific receptors on hematopoietic cells in the bone marrow, stimulating the proliferation, differentiation, and activation of neutrophil precursors. This increases the number of circulating neutrophils, enhancing the body’s ability to fight bacterial and fungal infections, especially in immunocompromised patients.

Dosage and Administration

• Dosage varies depending on the patient’s condition, body weight, and treatment regimen
• Administered as a subcutaneous or intravenous injection under medical supervision
• For chemotherapy-induced neutropenia, it is usually started 24 hours after chemotherapy and continued daily until neutrophil recovery
• Careful monitoring of complete blood count (CBC) is required to adjust dosing

Benefits

• Reduces the risk of infection in immunocompromised patients
• Accelerates neutrophil recovery following chemotherapy or bone marrow transplantation
• Supports safe continuation of chemotherapy by minimizing infection-related delays
• Enhances the success of stem cell mobilization for transplantation
• Improves overall patient outcomes and recovery in neutropenic conditions

Possible Side Effects

Common side effects may include:

• Bone pain or muscle aches
• Mild fever
• Headache
• Fatigue

Rare but serious side effects:

• Splenic enlargement or rupture
• Allergic reactions (rash, swelling, difficulty breathing)
• Thrombocytopenia or leukocytosis

Immediate medical attention is required for severe or unusual side effects.

Precautions and Warnings

• Use under strict medical supervision, especially in patients with prior hematologic disorders
• Monitor complete blood count regularly during treatment
• Use with caution in patients with splenic disorders, sickle cell disease, or known hypersensitivity to filgrastim
• Not recommended for patients with active myeloid malignancies without specialist guidance

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage Instructions

• Store in a refrigerator at 2°C–8°C; do not freeze
• Protect from light
• Keep the prefilled syringe or vial in its original packaging until use
• Do not shake vigorously

Conclusion

Ropenia Injection 300 mcg/0.5 ml (Filgrastim) is an effective therapy for patients with neutropenia caused by chemotherapy, bone marrow transplantation, or other immunocompromising conditions. By stimulating neutrophil production, it reduces infection risk, accelerates recovery, and supports better overall outcomes in patients requiring hematologic support.